Pharmachem Receives License to Use Weight, Glucose Management Claims

<p>Pharmachem Laboratories Inc., developer of the Phase 2 Carb Controller, has received a license from the Natural Health Products Directorate of Ottawa, Canada, to market their products using weight and glucose management claims.</p>

KEARNY, N.J.—Pharmachem Laboratories Inc., developer of the Phase 2 Carb Controller, has received a license from the Natural Health Products Directorate of Ottawa, Canada, to market their products using weight and glucose management claims.

Specifically, the company can make the following two claims:

·         At 6 capsules (3000 mg) per day, the product  assists in weight management when used with a program of reduced intake of dietary calories and increased physical activity.

·         At 4-6 capsules (2000-3000 mg) per day, it provides support for healthy glucose metabolism following a carbohydrate-rich meal.

The claim was made on behalf of Pharmachem by Dicentra of Toronto, Canada.

“The weight management claim is a real breakthrough because the requirements for the clinical trials required to gain the claim are quite stringent," said Ryan Ramdeo, regulatory affairs associate. “However, it was our belief that Phase 2 had the studies, the potency and safety to meet those requirements."

In June, the Phase 2 Carb Controller received generally recognized as safe (GRAS) status in the United States.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish